Association of circulating fibroblast growth factor-2 with progression of HIV-chronic kidney diseases in children
Authors:
- 14 June 2021
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 36 (12) , 3933-3944
Abstract
Background Children living with HIV frequently show high plasma levels of fibroblast growth factor-2 (FGF-2/bFGF). FGF-2 accelerates the progression of several experimental kidney diseases; however, the role of circulating FGF-2 in childhood HIV-chronic kidney diseases (HIV-CKDs) is unknown. We carried out this study to determine whether high plasma FGF-2 levels were associated with the development of HIV-CKDs in children. Methods The plasma and urine FGF-2 levels were measured in 84 children (< 12 years of age) living with HIV during the pre-modern antiretroviral era, and followed for at least 3 years to determine the prevalence of proteinuria and HIV-CKDs. We also assessed the distribution of the kidney FGF-2 binding sites by autoradiography and Alcian blue staining, and explored potential mechanisms by which circulating FGF-2 may precipitate HIV-CKDs in cultured kidney epithelial and mononuclear cells derived from children with HIV-CKDs. Results High plasma FGF-2 levels were associated with a high viral load. Thirteen children (~ 15%) developed HIV-CKDs and showed a large reservoir of FGF-2 low-affinity binding sites in the kidney, which can facilitate the recruitment of circulating FGF-2. Children with high plasma and urine FGF-2 levels had 73-fold increased odds (95% CI 9–791) of having HIV-CKDs relative to those with normal FGF-2 values. FGF-2 induced the proliferation and decreased the expression of APOL-1 mRNA in podocytes, and increased the attachment and survival of infected mononuclear cells cultured from children with HIV-CKDs. Conclusions High plasma FGF-2 levels appear to be an additional risk factor for developing progressive childhood HIV-CKDs. Graphical abstractKeywords
All Related Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK103564, R01 494919)
- National Institutes of Health (HL 102497)
This publication has 55 references indexed in Scilit:
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated NephropathyJournal of the American Society of Nephrology, 2011
- Role of fibroblast growth factor receptor signaling in kidney developmentAmerican Journal of Physiology-Renal Physiology, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Kidney Disease in HIV-Positive ChildrenSeminars in Nephrology, 2008
- Proteinuria in Children Infected with the Human Immunodeficiency VirusThe Journal of Pediatrics, 2008
- Novel cystogenic role of basic fibroblast growth factor in developing rodent kidneysAmerican Journal of Physiology-Renal Physiology, 2006
- Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndromeAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Heparan Sulfate Proteoglycans Function as Receptors for Fibroblast Growth Factor-2 Activation of Extracellular Signal–Regulated Kinases 1 and 2Circulation Research, 2004
- Serum Concentrations of Fibroblast Growth Factor 2 Are Increased in HIV Type 1-Infected Patients and Inversely Related to Survival ProbabilityAIDS Research and Human Retroviruses, 2001
- Basic fibroblast growth factor in HIV-associated hemolytic uremic syndromePediatric Nephrology, 1999